Breaking News Instant updates and real-time market news.

AMRN

Amarin

$19.91 /

-0.15 (-0.75%)

16:13
01/20/20
01/20
16:13
01/20/20
16:13

Amarin remains in 'good position' in ongoing patent trial, says Jefferies

Jefferies analyst Michael Yee maintains a Buy rating, with a $30 price target, on Amarin's shares as he believes the company remains in a "good position" to protect its patents on "infringement" and "obviousness." The analyst does not believe the generics have made a strong case or met the burden for proving they do not infringe, and obviousness.

AMRN Amarin
$19.91 /

-0.15 (-0.75%)

01/16/20 Jefferies
Amarin in 'good position' as 'heated' patent trial continues, says Jefferies
01/13/20 Roth Capital
Amarin's Vascepa now the 'go-to' after competitor failures, says Roth Capital
01/13/20 Stifel
Amarin should rally on failure of two potential competitors, says Stifel
01/13/20 JPMorgan
Epanova discontinuation positive for Amarin, says JPMorgan

TODAY'S FREE FLY STORIES

Hot Stocks
AstraZeneca divests global rights to Movantik » 07:00
02/25/20
02/25
07:00
02/25/20
07:00
AZN

AstraZeneca

$47.60 /

-2.57 (-5.12%)

AstraZeneca has agreed to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Macy's backs FY20 adj. EPS view $2.45-$2.65, consensus $2.75 » 07:00
02/25/20
02/25
07:00
02/25/20
07:00
M

Macy's

$15.44 /

-0.79 (-4.87%)

Backs FY20 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
FX Update: The yen has picked up bids » 07:00
02/25/20
02/25
07:00
02/25/20
07:00

FX Update: The yen has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Centogene names Dr. Vaibhav Joshi as Chief Data Officer » 06:58
02/25/20
02/25
06:58
02/25/20
06:58
CNTG

Centogene

$13.00 /

+1 (+8.33%)

Centogene announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Macy's CEO says pleased with significant trend improvement in Q4 » 06:58
02/25/20
02/25
06:58
02/25/20
06:58
M

Macy's

$15.44 /

-0.79 (-4.87%)

CEO Jeff Gennette says:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Macy's reports Q4 adj. EPS $2.12, consensus $1.96 » 06:57
02/25/20
02/25
06:57
02/25/20
06:57
M

Macy's

$15.44 /

-0.79 (-4.87%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Aurinia Pharmaceuticals names Max Colao as Chief Commercial Officer » 06:56
02/25/20
02/25
06:56
02/25/20
06:56
AUPH

Aurinia Pharmaceuticals

$19.27 /

-1.13 (-5.54%)

, ALXN

Alexion

$99.14 /

-4.03 (-3.91%)

, AMGN

Amgen

$217.88 /

-4.92 (-2.21%)

Aurinia Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
NGM Biopharmaceuticals price target raised to $34 from $31 at Citi » 06:56
02/25/20
02/25
06:56
02/25/20
06:56
NGM

NGM Biopharmaceuticals

$18.83 /

+2.83 (+17.69%)

Citi analyst Joel Beatty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Deluxe to host analyst day » 06:55
02/25/20
02/25
06:55
02/25/20
06:55
DLX

Deluxe

$38.57 /

-0.61 (-1.56%)

Analyst day to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
1Life Healthcare initiated with a Neutral at Citi » 06:54
02/25/20
02/25
06:54
02/25/20
06:54
ONEM

1Life Healthcare

$22.32 /

-1.6 (-6.69%)

Citi analyst Ralph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
EnPro sees FY20 adjusted cont. ops EPS $2.82-$3.14, consensus $2.83 » 06:53
02/25/20
02/25
06:53
02/25/20
06:53
NPO

EnPro

$58.23 /

-1.505 (-2.52%)

Sees Fy20 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
Earnings
Itron sees FY20 EPS $3.35-$3.85, consensus $3.56 » 06:53
02/25/20
02/25
06:53
02/25/20
06:53
ITRI

Itron

$78.57 /

-6.51 (-7.65%)

Sees FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
NIO Inc. upgraded to Market Perform from Underperform at Bernstein » 06:52
02/25/20
02/25
06:52
02/25/20
06:52
NIO

NIO Inc.

$3.88 /

-0.195 (-4.79%)

Bernstein analyst Robin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Palo Alto Networks price target lowered to $250 from $283 at Citi » 06:52
02/25/20
02/25
06:52
02/25/20
06:52
PANW

Palo Alto Networks

$236.99 /

-5.87 (-2.42%)

Citi analyst Walter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
EnPro reports Q4 adjusted EPS 57c, consensus 30c » 06:52
02/25/20
02/25
06:52
02/25/20
06:52
NPO

EnPro

$58.23 /

-1.505 (-2.52%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
Hot Stocks
DPW Holdings enters settlement agreement in derivative action » 06:50
02/25/20
02/25
06:50
02/25/20
06:50
DPW

DPW Holdings

$1.73 /

-0.03 (-1.70%)

DPW Holdings announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Palo Alto Networks price target lowered to $245 from $265 at Mizuho » 06:49
02/25/20
02/25
06:49
02/25/20
06:49
PANW

Palo Alto Networks

$236.99 /

-5.87 (-2.42%)

Mizuho analyst Gregg…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
AIG announces $500M accelerated share repurchase plan » 06:49
02/25/20
02/25
06:49
02/25/20
06:49
AIG

AIG

$45.68 /

-2.92 (-6.01%)

American International…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Wendy's initiated with a Buy at Northcoast » 06:48
02/25/20
02/25
06:48
02/25/20
06:48
WEN

Wendy's

$23.40 /

-0.52 (-2.17%)

Northcoast analyst Jim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Easterly Government Properties backs FY20 FFO view $1.22-$1.24  06:48
02/25/20
02/25
06:48
02/25/20
06:48
DEA

Easterly Government Properties

$25.03 /

-0.23 (-0.91%)

FY20 consensus $1.23.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Deutsche Bank downgrades Palo Alto to Hold, cuts target to $210 from $275 » 06:47
02/25/20
02/25
06:47
02/25/20
06:47
PANW

Palo Alto Networks

$236.99 /

-5.87 (-2.42%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
TopBuild sees FY20 revenue $2.765B-$2.835B, consensus $2.8B » 06:47
02/25/20
02/25
06:47
02/25/20
06:47
BLD

TopBuild

$121.30 /

-1.76 (-1.43%)

Sees FY20 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
TopBuild reports Q4 adjusted EPS $1.48, consensus $1.42 » 06:45
02/25/20
02/25
06:45
02/25/20
06:45
BLD

TopBuild

$121.30 /

-1.76 (-1.43%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Easterly Government Properties reports Q4 AFFO 31c, consensus 30c » 06:45
02/25/20
02/25
06:45
02/25/20
06:45
DEA

Easterly Government Properties

$25.03 /

-0.23 (-0.91%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
HSBC double downgrades AB InBev on long-term structural problems » 06:43
02/25/20
02/25
06:43
02/25/20
06:43
BUD

AB InBev

$69.36 /

-2.24 (-3.13%)

HSBC analyst Carlos Laboy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.